TTM Technologies Other Income (Expense) increased by 25.7% to -$13.92M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 50.2%, from -$9.27M to -$13.92M. Over 3 years (FY 2021 to FY 2025), Other Income (Expense) shows relatively stable performance with a -1.0% CAGR.
An increase suggests higher non-operating gains or lower non-operating costs, while a decrease indicates higher non-operating expenses or lower non-operating income.
Represents the net total of non-operating financial activities, including interest income, interest expense, foreign cur...
Standard across all public companies; peers in the medical device sector often show similar volatility due to currency fluctuations.
other_income_expense_net| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$10.77M | -$8.62M | -$12.44M | -$9.39M | -$3.07M | -$615.00K | -$14.47M | -$10.27M | -$8.00M | -$7.06M | -$16.69M | -$3.00M | -$8.45M | -$25.95M | -$9.27M | -$16.24M | -$10.09M | -$18.74M | -$13.92M |
| QoQ Change | — | +20.0% | -44.3% | +24.5% | +67.3% | +80.0% | <-999% | +29.0% | +22.1% | +11.8% | -136.6% | +82.0% | -182.0% | -206.9% | +64.3% | -75.3% | +37.9% | -85.7% | +25.7% |
| YoY Change | — | — | — | — | +71.5% | +92.9% | -16.2% | -9.4% | -160.3% | <-999% | -15.4% | +70.8% | -5.7% | -267.6% | -209.2% | -92.1% | +61.1% | — | -50.2% |